Effect of somatostatin on normal and gastric-stimulated cell proliferation in the gastric and intestinal mucosae of the rat.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMID 478195)

Published in Digestion on January 01, 1979

Authors

T Lehy, M Dubrasquet, S Bonfils

Articles citing this

Octreotide effectively decreases mucosal damage in experimental colitis. Gut (1993) 0.89

Hormonal regulation of physiological cell turnover and apoptosis. Cell Tissue Res (2000) 0.89

Growth and transformation of the small intestinal mucosa--importance of connective tissue, gut associated lymphoid tissue and gastrointestinal regulatory peptides. Gut (1989) 0.86

Preclinical evaluation of Som230 as a radiation mitigator in a mouse model: postexposure time window and mechanisms of action. Radiat Res (2011) 0.86

Somatostatin binding in normal and malignant human gastrointestinal mucosa. Br J Cancer (1992) 0.85

Epithelial response of the rat gastric mucosa to chronic superficial injury. Yale J Biol Med (1997) 0.84

Somatostatin analogue (octreotide) inhibits bile duct epithelial cell proliferation and fibrosis after extrahepatic biliary obstruction. Am J Pathol (1993) 0.83

Effect of glucagon on protein synthesis in human rectal cancer in situ. Ann Surg (1998) 0.80

Effects of hypochlorhydria and hypergastrinemia on structure and function of gastrointestinal cells. A review and analysis. Dig Dis Sci (1995) 0.80

Effect of somatostatin on the growth of gastrointestinal mucosa and pancreas in rats. Role of endogenous gastrin. Gut (1987) 0.78

Effect of hypophysectomy on endocrine cell types in rat gastrointestinal mucosa. J Anat (1997) 0.75

Assays of damage to the alimentary canal. Br J Cancer Suppl (1986) 0.75

Somatostatin antagonism prevents elemental diet-induced intestinal atrophy in the rat. Dig Dis Sci (2001) 0.75

Articles by these authors

The stomach is a source of leptin. Nature (1998) 3.33

Leptin secretion and leptin receptor in the human stomach. Gut (2000) 2.46

Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera. Dig Dis Sci (1982) 2.14

Utilization of paraffin-embedded material for electron microscopy. Study of an A2-cell type microadenoma of the endocrine pancreas. Lab Invest (1970) 1.70

[The automatic determination of proteolytic activity of gastric juice]. Biol Gastroenterol (Paris) (1968) 1.60

[How to express results of 24-hour gastric pH measurement? Choice of a mode of expression in 27 healthy subjects]. Gastroenterol Clin Biol (1989) 1.51

Results of surgical management in 92 consecutive patients with Zollinger-Ellison syndrome. Ann Surg (1981) 1.27

Prevalence of high-grade dysplasia and cancer in the anal canal in human papillomavirus-infected individuals. Gastroenterology (2001) 1.22

Leptin stimulates the proliferation of human colon cancer cells in vitro but does not promote the growth of colon cancer xenografts in nude mice or intestinal tumorigenesis in Apc(Min/+) mice. Gut (2005) 1.13

Cimetidine treatment of acute and chronic Zollinger-Ellison syndrome. World J Surg (1979) 1.11

Current approach to the management of tumoral process in patients with gastrinoma. World J Surg (1986) 1.09

Hepatocyte growth factor induces colonic cancer cell invasiveness via enhanced motility and protease overproduction. Evidence for PI3 kinase and PKC involvement. Carcinogenesis (2001) 1.09

Diagnosis and treatment of Zollinger-Ellison syndrome. Baillieres Clin Gastroenterol (1988) 1.07

Radioautographic and quantitative studies on parietal and peptic cell kinetics in the mouse. A selective effect of gastrin on parietal cell proliferation. Gastroenterology (1975) 1.06

Chronic endogenous hypergastrinemia in humans: evidence for a mitogenic effect on the colonic mucosa. Gastroenterology (1993) 1.04

Population kinetics of antral gastrin cells in the mouse. Gastroenterology (1976) 1.03

Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome. Gut (1992) 1.03

Evaluation of antisecretory drug therapy of Zollinger-Ellison syndrome (ZES) using 24-hour pH monitoring. Dig Dis Sci (1983) 1.02

Stimulating effect of bombesin on the growth of gastrointestinal tract and pancreas in suckling rats. Gastroenterology (1986) 1.00

Delayed gastric emptying in anorexia nervosa is improved by completion of a renutrition program. Dig Dis Sci (1988) 0.97

Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type I multiple endocrine neoplasia. Pancreas (1993) 0.97

Gastric endocrine cell behavior in Zollinger-Ellison patients upon long-term potent antisecretory treatment. Gastroenterology (1989) 0.97

Gastric HCO3-stimulated ATPase: evidence against its microsomal localization in rat fundus mucosa. Biochim Biophys Acta (1974) 0.96

C1-transport in gastric micorsomes. An ATP-dependent influx sensitive to membrane potential and to protein kinase inhibitor. J Biol Chem (1980) 0.95

Determination of histamine, methylhistamines and histamine-o-phthaldialdehyde complexes by two high-performance liquid chromatographic procedures. Application to biological samples. J Chromatogr (1983) 0.93

Acute spontaneously recovering ulcerating colitis (ARUC). Report of 6 cases. Am J Dig Dis (1977) 0.93

[Efficacy of ranitidine and cimetidine in the treatment of gastric or duodenal ulcer resistant to an initial treatment with cimetidine. Multicenter controlled therapeutic trial]. Gastroenterol Clin Biol (1985) 0.92

Metabolic clearance rates of oxyntomodulin and glucagon in the rat: contribution of the kidney. Regul Pept (1990) 0.92

Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in rats. Carcinogenesis (1999) 0.91

Development of gastric argyrophil carcinoid tumors in a case of Zollinger-Ellison syndrome with primary hyperparathyroidism during long-term antisecretory treatment. Cancer (1987) 0.91

Parietal and chief cell populations in four cases of the Zollinger-Ellison syndrome. Gastroenterology (1972) 0.91

Developmental expression of transforming growth factor-alpha and epidermal growth factor receptor proteins in the human pancreas and digestive tract. Cell Tissue Res (1994) 0.91

Detection of gastrin mRNA in human antral mucosa and digestive endocrine tumors by in situ hybridization: a correlative study with immunocytochemistry and electron microscopy. J Histochem Cytochem (1992) 0.90

Glycine-extended gastrin promotes the invasiveness of human colon cancer cells. Biochem Biophys Res Commun (2001) 0.89

Gastric endocrine cell evolution in patients with Zollinger-Ellison syndrome. Influence of gastrinoma growth and long-term omeprazole treatment. Dig Dis Sci (1993) 0.88

Effect of the histamine-1 antagonist astemizole alone or with omeprazole on rat gastric mucosa. Scand J Gastroenterol (1991) 0.88

Central inhibition of basal pancreatic and gastric secretions by beta-endorphin in rats. Gastroenterology (1980) 0.88

Oxyntomodulin (glucagon-37 or bioactive enteroglucagon): a potent inhibitor of pentagastrin-stimulated acid secretion in rats. Biosci Rep (1982) 0.88

Inhibitory effect of prolonged administration of long-acting somatostatin on gastrin-stimulated fundic epithelial cell growth in the rat. Digestion (1982) 0.87

Ranitidine upon meal-induced gastric secretion: oral pharmacokinetics and plasma concentration effect relationships. Br J Clin Pharmacol (1982) 0.87

Carrageenan: effects in animals. Lancet (1970) 0.87

[Histological and cytological study of the tumoral and nontumoral endocrine pancreas in the Zollinger-Ellison syndrome]. Rev Int Hepatol (1966) 0.87

Opposite effects of gastrin on cell proliferation in the antrum and other parts of the upper-gastrointestinal tract in the rat. Am J Dig Dis (1977) 0.86

Chronic administration of bombesin stimulates antral gastrin cell proliferation in the rat. Gastroenterology (1983) 0.85

New somatostatin molecule for management of endocrine tumours. Gut (1985) 0.85

Current approach to the management of gastrinoma and insulinoma in adults with multiple endocrine neoplasia type I. World J Surg (1993) 0.85

A quality of life study in five hundred and eighty-one duodenal ulcer patients. Maintenance versus intermittent treatment with nizatidine. Scand J Gastroenterol Suppl (1994) 0.85

Jejunal absorption, pharmacological activity, and pharmacokinetic evaluation of indomethacin-loaded poly(d,l-lactide) and poly(isobutyl-cyanoacrylate) nanocapsules in rats. Pharm Res (1991) 0.85

BI-RADS categorisation of 2,708 consecutive nonpalpable breast lesions in patients referred to a dedicated breast care unit. Eur Radiol (2011) 0.84

Carrageenan and the human gut. Lancet (1970) 0.84

Management of Zollinger-Ellison syndrome. N Engl J Med (1980) 0.84

Correlative immunocytochemical and electron microscopic studies: identification of (entero)glucagon- somatostatin- and pancreatic polypeptide-like-containing cells in the human colon. Histochemistry (1981) 0.84

[An approach to automatic determination of the proteolytic activity of gastric juice under conditions of initial reaction rate]. Biol Gastroenterol (Paris) (1975) 0.84

Ranitidine and cimetidine in Zollinger-Ellison syndrome. Br J Clin Pharmacol (1980) 0.84

Is the multiple endocrine neoplasia type 1 gene a suppressor for fundic argyrophil tumors in the Zollinger-Ellison syndrome? Gastroenterology (1993) 0.84

Chromogranin A and pancreastatin-like immunoreactivity in serum of gastrinoma patients. Acta Oncol (1993) 0.84

[Influence of rectal preparation by enema on cell proliferation in the normal rectal mucosa in man]. Gastroenterol Clin Biol (1984) 0.84

Bombesin ingestion stimulates epithelial digestive cell proliferation in suckling rats. Am J Physiol (1989) 0.84

[Letter: Inhibitor of H 2 histamine receptors and the Zollinger-Ellison syndrome]. Nouv Presse Med (1974) 0.83

Detection and localization by in situ molecular biology techniques and immunohistochemistry of hepatitis C virus in livers of chronically infected patients. J Histochem Cytochem (1998) 0.83

Gynecomastia and histamine-2 antagonists. Lancet (1982) 0.83

Interest of a combined antisecretory treatment, cimetidine and pirenzepin, in the management of severe forms of Zollinger-Ellison syndrome. Digestion (1980) 0.83

Pharmacokinetic evaluation of indomethacin nanocapsules. Drug Des Deliv (1989) 0.83

Trophic effect of some regulatory peptides on gastric exocrine and endocrine cells of the rat. Scand J Gastroenterol Suppl (1984) 0.82

[Initial results with caerulein in pancreatic function tests in man]. Acta Gastroenterol Belg (1971) 0.82

[Isolation and purification of a histamine-like gastrosecretagogue from gastric antral mucosa]. Gastroenterol Clin Biol (1982) 0.82

A 'quality of life questionnaire' adapted to duodenal ulcer therapeutic trials. Scand J Gastroenterol Suppl (1994) 0.82

Histamine is able to suppress the inhibitory effect of somatostatin on exogenous gastrin: comparison between extractive antral histamine and synthetic histamine. Agents Actions (1983) 0.82

Quantitation of gastrin and somatostatin cell populations in the antral mucosa of the rat. Comparative distribution and evolution through different life stages. Cell Tissue Res (1979) 0.82

Comparative effects of antrocolic transposition and antrectomy on fundic mucosa and acid secretion of the rat. Gastroenterology (1973) 0.81

[Effect of a gastrin agonist isolated from antral mucosa on gastric secretion (author's transl)]. J Physiol (Paris) (1980) 0.81

Epithelial cell proliferation in the rectal stump of patients with ileorectal anastomosis for ulcerative colitis. Gut (1983) 0.81

Gastrin cell hyperplasia in rats with chronic antral stimulation. Gastroenterology (1975) 0.81

Interaction of 3H-labelled synthetic human gastrin I with rat gastric plasma membranes. Evidence for the existence of biologically reactive gastrin receptor sites. FEBS Lett (1976) 0.81

Cholecystokinin suppresses food intake in cats: structure-activity characterization. Pharmacol Biochem Behav (1988) 0.81

Developmental expression of transforming growth factor-alpha in the upper digestive tract and pancreas of the rat. Regul Pept (1995) 0.81

Transforming growth factor-alpha in vivo stimulates epithelial cell proliferation in digestive tissues of suckling rats. Gut (1996) 0.81

[Efficacy of combined anti-secretory treatment (cimétidine and pirenzepin) in Zollinger-Ellison syndrome]. Nouv Presse Med (1977) 0.81

Transforming growth factor-alpha and epidermal growth factor receptor in colonic mucosa in active and inactive inflammatory bowel disease. Growth Factors (2000) 0.81

[Rat bioassay with urine (PSU) for diagnosis and postoperative follow-up in Zollinger-Ellison syndrome (author's transl)]. Acta Gastroenterol Belg (1973) 0.81

Two peptides derived from the nerve growth factor precursor are biologically active. J Cell Biol (1997) 0.81

Gastric endocrine cell proliferation and fundic argyrophil carcinoid tumors in patients with the Zollinger-Ellison syndrome. Acta Oncol (1993) 0.81

Long-term treatment with octreotide in patients with the Zollinger-Ellison syndrome. Eur J Clin Invest (1993) 0.81

Fine structural classification and comparative distribution of endocrine cells in normal human large intestine. Gastroenterology (1978) 0.81

Antral mucosa expresses functional leptin receptors coupled to STAT-3 signaling, which is involved in the control of gastric secretions in the rat. Gastroenterology (2001) 0.81

A comparative evaluation of secretin bolus and secretin infusion as secretin provocation tests in the Zollinger-Ellison syndrome. Scand J Gastroenterol (1985) 0.81

Comparative development of gastrin and somatostatin cell populations in the pancreas, stomach, and duodenum of the rat during the perinatal period. Anat Rec (1987) 0.80

Action of somatostatin analogue (SMS 201-995) on the growth-promoting effect resulting from sustained achlorhydria in rat gastric mucosa, with special reference to endocrine cell behaviour. Eur J Clin Invest (1988) 0.80